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  ABSTRACT 
Introduction: Diabetes mellitus is a disease since antiquity. It is emerging as a pandemic in 
the society. Though a lot of potent antidiabetic drugs are available today but none of them is 
free from untoward effects. A number of Ayurvedic herbal drugs are effective in the 
management of diabetes mellitus. But most of these drugs are required to be taken in bulk 
invariably for long span hence some time their poor palatability becomes a big problem. 
Moreover which herbal is more potent and in which particular situation it is more suitable 
also needs to be evaluated. 
Objective: This study was conducted to clinically evaluate comparative efficacy of 
Neelkanthi Churna, Tejapatra and Methika Beeja Churna in the management of diabetes 
mellitus. 
Materials and Methods: The study was conducted as a part of post graduate thesis 
research work. Total 45 patients of diabetes mellitus were registered in the present clinical 
study and they were administered trial drugs for the duration of 45 days. Registered 
patients were randomly divided into two groups. In group-I patients were managed with 
Tejapatra and Methika Beeja Churna. Group-II patients were managed with Neelkanthi 
Churna. 
Observations and conclusion: Patients were thoroughly assessed on various parameters 
during complete trial period. Though both Churna of Neelkanthi and Churna of Tejapatra 
and Methika Beeja were found significantly effective in the management of Madhumeha but 
Churna of Neelkanthi showed definitely better effect on various subjective, objective and 
biochemical parameters. No untoward effect was noticed during treatment and follow up 
period. 
KEY WORDS: Madhumeha, Diabetes mellitus, Neelkanthi, Tejpatra, Methika, herbal drugs. 
INTRODUCTION
Diabetes mellitus is a disease since 
antiquity. Today the whole world is facing a 
pandemic of diabetes mellitus. Globally and 
nationally diabetes mellitus with its complications 
has become one of the most important challenging 
health problem. Changing life style, lack of 
exercise, fast foods, improper diet and sedentary 
life are showing upward trend in India. This has 
lead to the emergence of diabetes mellitus in this 
region. A number of Ayurvedic herbal drugs are 
effective in the management of Madhumeha. 
Neelkanthi, Tejapatra and Methika Beeja are also 
among them. But as the anti diabetic drugs are 
required to be taken in bulk invariably for long 
span hence some time their poor palatability 
becomes a big problem. Moreover which herbal is 
more potent and in which particular situation it is 
more suitable also needs to be evaluated. In the 
present study, comparative efficacy of Neelkanthi 
Churna, Tejapatra and Methika Beeja Churna has 
been clinically assessed in type-II diabetes 
mellitus patients.  
Objectives of the Research work 
To clinically evaluate comparative efficacy 
of Neelkanthi Churna (Ajuga bracteosa wall. ex 
benth), Tejapatra (Cinnamomum tamala) and 
Methika Beeja Churna (Trigonella foenum 
graecum) in the management of diabetes mellitus. 
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Location/ Setting: The study was conducted as a 
part of post graduate thesis research work in P.G. 
department of Kayachikitsa (Medicine) of Rajiv 
Gandhi Govt. Post Graduate Ayurvedic College & 
Hospital Paprola, Himachal Pradesh in the year 
2011. 
MATERIALS AND METHODS 
The present study was open, single blind 
and double group in nature. The study was 
conducted on 45 patients of diabetes mellitus 
selected from OPD and IPD of associated hospital 
of Rajiv Gandhi Govt. Post Graduate Ayurvedic 
College, Paprola (H.P.). Patients of type-II diabetes 
mellitus in the age group of 35-80 years were 
registered irrespective of caste, sex, race and 
religion after obtaining their written informed 
consent. 5 patients did not turn up for follow up. 
They were considered dropped out from the 
study. Remaining 40 patients completed the trial.  
Criteria for Diagnosis 
1. Subjective Criteria: Classical signs and 
symptoms of Madhumeha mentioned in 
Ayurvedic texts as well as in modern 
medicines. 
2. Objective Criteria: Fasting blood glucose > 
126 mg/dl. 
Inclusion Criteria 
1. Age between 35-80 years. 
2. Patients with FBS > 126 mg/dl. 
3. Only uncomplicated cases of type-II diabetes 
mellitus. 
Exclusion Criteria 
1. Patients presenting with complications like 
severe renal disease, retinopathy, ischaemic 
heart disease, severe hypertension etc. 
2. type-I diabetes mellitus. 
3. Patients underwent pancreatic or liver 
surgery. 
4. Patients having associated major medical 
diseases like cancer and concurrent 
infection like tuberculosis etc. 
Method of Study: Total 45 patients of type-II 
diabetes mellitus were selected for the present 
clinical study, they were randomly divided into 
two groups and treatment was given as follows:  
i. Group I: Total 23 patients were registered in 
trial group I and out of them 3 patients 
discontinued the treatment and only 20 
patients completed the study, the selected 
patients were given the trial drugs i.e. 
Tejpatra and Methika Beeja Churna in equal 
quantity in the dose of 10 gms, twice a day 
with plain water before food. 
ii. Group II: Total 22 patients were registered 
in trial group II and out of them 2 patients 
discontinued the treatment and only 20 
patients completed the study, the selected 
patients were given Neelkanthi Churna in a 
dose of 2 gms twice a day with plain water 
before food. 
Preparation of trial drugs 
Trial drugs were prepared in state 
Ayurvedic pharmacy Paprola, which is G.M.P. 
certified. Neelkanthi (Ajuga bracteosa wall. ex 
benth) whole plant was grinded to prepare fine 
powder. Tejapatra (Cinnamomum tamala) leaves 
and Methika (Trigonella foenum graecum) seeds 
were also grinded to prepare fine powder. 
Investigations: Following investigations were 
carried out to rule out any other concomitant 
disease, secondary hypertension and to see any 
untoward effect of the trial drugs both before and 
after the therapy. 
Blood: Fasting blood sugar and urine- routine and 
microscopic examination were done at every15 
days till the completion of trial. Other 
investigations which were carried out both before 
and after the therapy are as under: 
Blood: Hb%, TLC, DLC, ESR, Blood Urea, S. 
Creatinine, Lipid profile (LDL, VLDL, HDL, S. 
Triglycerides, S. Cholesterol), S.G.O.T., S.G.P.T. 
Duration of Trial: 45 days. 
Data Collection and Statistical Analysis: Data 
generated from clinical study was collected and 
analyzed statistically. The improvement in the 
status of patient was assessed on the grades of 
various variables compared between pre-trial and 
post-trial values in terms of percentage (based on 
mathematical mean and its difference) and the 
student ‘t’ tests was applied wherever it was felt 
necessary by using degree of freedom value. The 
results were interpreted at the level of p<0.001 as 
highly significant, p<0.01 as moderately 
significant, p<0.05 as significant and p>0.05 as 
insignificant. 
Instructions to the Patients: Patients of both the 
groups were given similar advice regarding diet 
and exercise. All the patients were advised to take 
plenty of green leafy vegetables and to avoid high 
glycemic index food and fats. They were further 
advised to take light exercises daily and to avoid 
strenuous physical exercise. 
Criteria for Assessment: Registered patients 
were thoroughly assessed for any improvement in 
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the subjective and objective criteria after every 15 
days till the completion of trial of 45 days. 
Haematological, biochemical and urine 
examination were done both before and after the 
therapy. Various signs and symptoms and urine 
sugar were accorded grades according to the 
severity as under: 
Table 1: Grading of symptoms 
Symptoms Grade 
Absent 0 
Mild 1 
Moderate 2 
Severe 3 
Table 2: Grading of Urine Sugar 
Urine Sugar Grade 
Nil 0 
Trace 1 
+ 2 
++ 3 
+++ 4 
++++ 5 
Observations: Statistically highly significant 
(p<0.001) reduction in fasting blood sugar was 
observed in both groups (Group-I 35.75%, group-
II 40.99%). But intergroup difference was 
insignificant statistically (p>0.05). (Table 3)  
Statistically moderately significant 
(p<0.01) reduction in urine sugar was observed in 
group-I (71%). In group-II urine sugar reduction 
was 80%, which was also statistically highly 
significant (p<0.001). But intergroup difference 
was insignificant statistically (p>0.05). (Table 4)  
Statistically highly significant reduction in 
polyuria, polydipsia, polyphagia, fatigue, 
numbness, burning sensation of hands and feet, 
calf tenderness, dryness of mouth, joint pains and 
vulval pruritus/balanitis in both groups. However 
intergroup difference was insignificant 
statistically (p>0.05) for all features except 
polyuria. (Table 5).  
Haemoglobin, TLC, DLC, ESR, blood urea 
and serum creatinine, SGOT, SGPT were within 
normal limits before starting of therapy and 
remained so after completion of trial in both the 
groups and statistically insignificant effect was 
observed in both the groups after the therapies. In 
Group-I patients serum lipid profile status was 
statistically significantly improved (p<0.001) 
whereas in no change was observed in Group-II 
(p>0.05). (Table 6) 
Trial Drugs Pictures 
 
Tejapatra + Methika Beeja Churna 
 
Neelkanthi Churna 
Table 3: Comparative effect of therapy on fasting blood sugar 
Variable 
(Mean 
score) 
Trial Group I Trial Group II Comparison 
Mean score % 
change 
+ SE t p Mean score % 
Change 
+ SE t p I Vs II ‘t’ P 
BT AT BT AT 
Fasting 
Blood 
Sugar 
176.5 113.4 35.75 5.42 11.86 <0.001 173.3 102.25   40.99  <0.001 12.8 <0.001 0.85  >0.05 
Table 4: Comparative effect of therapy on Urine Sugar 
Variable 
(Mean 
score) 
Trial Group I Trial Group II Comparison 
Mean score % 
change 
+ SE T p Mean score % 
change 
+ 
SE 
T p I Vs II 
‘t’ 
p 
BT AT BT AT 
 Urine 
Sugar 
2 0.58 71 0.34 4.14 <0.01 1.84 0.30 83 0.26 5.88 <0.001 0.38 >0.05 
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Table 5: Comparative effect of therapy on symptoms 
Signs/ 
Symptoms 
Trial Group I Trial Group II Comparison 
Mean score % 
change 
+ SE t P Mean score % 
change 
+ SE t p I Vs II 
‘t’ 
P 
BT AT BT AT 
 Polyuria 0.91 0.17 81 0.07 10.71 <0.001 1.63 0.05 96 0.15 10.26 <0.001 3.6 <0.01 
 Polydipsia 1.36 0.36 73 00 00 <0.05 1.50 0.20 86 0.15 8.66 <0.001 2 >0.05 
 Polyphagia 1.45 0.36 75 0.09 12.11 <0.001 1.40 0.20 85 0.13 9.23 <0.001 0.27 >0.05 
Fatigue 1.40 0.30 78 0.09 12.22 <0.001 1.40 0.20 85 0.13 9.23 <0.001 0.62 >0.05 
 Numbness 1.30 0.20 84 0.09 12.22 <0.001 1.54 0.18 88 0.07 19.42 <0.001 2.03 >0.05 
 burning 
sensation in 
 hands and feet 
1.72 0.45 73 0.13 9.76 <0.001 1.70 0.30 82 0.08 17.5 <0.001 0.86 >0.05 
 calf 
tenderness 
1.44 0.44 69 00 00 <0.05 1.44 0.22 84 0.15 8.00 <0.001 1.54 >0.05 
dryness of 
mouth 
1.75 0.50 86 0.29 4.31 <0.01 1.54 0.18 88 0.15 8.66 <0.001 0.36 >0.05 
joint pains 1.45 0.36 75 0.02 54.50 <0.001 1.45 0.18 87 0.14 8.57 <0.001 1.28 >0.05 
Vulval 
pruritus/Bala
nitis 
1.55 0.33 78 0.14 8.57 <0.001 1.57 0.28 82 0.19 6.31 <0.001 0.27 >0.05 
Table 6: Comparative effect of therapy on lab parameters 
Variable Group-I Group – II 
Mean Score % 
Change 
SD SE + t P Mean Score % 
Change 
SD SE + t P 
BT AT BT AT 
Haemoglobin 10.63 10.83 02.06 0.93 0.16 1.38 >0.05 10.80 10.91 01.02 0.44 0.065 1.69 >0.05 
TLC 7414.2 7354.2 00.88 288.7 48.77 1.23 >0.05 6956.8 6920 00.53 1163 173.4 0.97 >0.05 
ESR 16.91 16.02 05.26 3.49 0.59 1.49 >0.05 17.47 17.15 01.83 2.74 0.41 0.76 >0.05 
Polymorphs 64.88 64.11 01.19 3.26 0.55 1.40 >0.05 62.37 63.64 02.03 6.31 0.94 0.85 >0.05 
Lymphocytes 31.54 32.23 02.19 2.28 0.38 1.79 >0.05 33.84 30.00 11.34 5.38 0.80 0.51 >0.05 
Monocytes 00.83 01.14 37.34 0.93 0.16 1.94 >0.05 01.16 01.27 09.48 0.96 0.14 0.77 >0.05 
Eosinophils 02.74 02.28 00.17 1.24 0.21 1.09 >0.05 02.82 02.73 03.14 1.08 0.16 0.56 >0.05 
B. Urea 32.28 31.80 01.50 3.10 0.52 00.92 >0.05 28.07 27.51 1.99 2.03 0.302 1.98 >0.05 
S.Creatinine 00.94 00.92 02.12 0.12 0.02 01.25 >0.05 00.97 00.93 4.12 0.14 0.021 1.90 >0.05 
SGOT 26.17 25.83 01.31 1.75 0.29 01.25 >0.05 24.80 24.47 1.33 1.79 0.27 1.41 >0.05 
SGPT 27.83 27.28 01.95 2.56 0.43 01.93 >0.05 23.20 23.29 0.38 2.15 0.32 1.125 >0.05 
S. Cholesterol 223.75 192.85 14.25 8.30 1.85 16.97 <0.001 214.38 214 0.001 2.76 0.41 0.88 >0.05 
S. Triglyceride 152.8 128.4 15.96 4.18 0.93 26.23 <0.001 147.48 147 0.003 2.34 0.35 1.26 >0.05 
HDL 45.4 52.1 14.75 1.75 0.39 17.17 <0.001 37.13 37.46 0.88 1.53 0.23 1.35 >0.05 
LDL 138.25 118.75 14.10 7.55 1.68 11.60 <0.001 139.22 139 0.001 1.06 0.16 1.25 >0.05 
VLDL 48.90 40.60 16.97 3.69 0.82 14.51 <0.001 37.80 37.47 0.87 1.43 0.21 1.57 >0.05 
DISCUSSION 
It has been established that Tejpatra 
Churna used in crude form contains more fibre 
which reduce glucose absorption from gut by 
inhibiting galactocidase and glucocidase. This 
drug can also be assumed to be acting at the level 
of pancreatic β-cells and thus increasing the 
insulin release. This can be explained on the basis 
that Tejpatra contain many aromatic oils and is 
widely used in spices. Now it is proved that all the 
spices help in activating the secretion of various 
digestive enzymes and hormones which helps in 
proper digestion and metabolism[1]. So it appears 
that Tejpatra may also stimulate directly or 
indirectly the β-cells of pancreas for proper 
insulin secretion and have hypoglycaemic 
effects[2]. Fenu greek seeds are used in crude form, 
the seeds contain more fibre which helps in 
reducing glucose absorption from gut, leading to 
reduced glucose load in blood. Fenu greek seeds 
contain the unique major free amino acid 4 - 
hydroxy isoleucine (4–OH – 11e) which has been 
characterized as one of the active ingredients in 
fenu greek for blood glucose control. Another 
mechanism mentioned about the trial drug is that, 
it may be acting against the formation of islet 
amyloid polypeptide (IAPP). It had been 
discovered that IAPP to be occurring in human 
insulinomas and in pancreatic islets with type-II 
diabetes mellitus, which have shown to inhibit 
insulin secretion and have hypoglycaemic effects 
[3,4]. Neelkanthi Churna is Tikta in taste, having 
Sheeta Veerya and Katu Vipaka, no anti-diabetic 
action of Neelkanthi Churna has been mentioned 
in Ayurvedic texts, but by virtue of its properties it 
acts as Madhumehahara Aushada. This is a folklore 
medicine wildly used in this area for the treatment 
of Madhumeha. The leaves contain more fibre 
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which helps in reducing glucose absorption from 
gut, leading to reduced glucose load in blood. This 
drug had been researched and proved to have 
hypoglycaemic effect[5]. 
CONCLUSIONS  
On the basis of results obtained, it is clear 
that all three trial herbal drugs i.e. Neelkanthi 
(Ajuga bracteosa wall. ex benth), Tejapatra 
(Cinnamomum tamala) and Methika Beeja 
(Trigonella foenum graecum) possess statistically 
significant hypoglycaemic activity. However 
Neelkanthi Churna showed definitely better 
efficacy over Tejpatra and Methika Beeja Churna in 
reducing fasting blood sugar, urine sugar and 
various subjective features of diabetes mellitus 
with no observed side effects. However Tejapatra 
and Methika Beeja may prove more useful in 
managing the type II diabetes mellitus patients 
having concomitant dyslipidemia as these drugs 
also possess significant hypolipidemic 
activities[6,7]. More studies are required for 
thorough assessment of antidiabetic potential of 
trial drug. 
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